Patent ID: 11856945
Assignee: WASHINGTON UNIVERSITY
Field: Measurement (Instruments)
Classification: CPC A  G  C | IPC A  C  G

Claim 9:
10. The method according to claim 1, wherein the at least one target analyte comprises at least one of a biomarker, a protein biomarker, a protein therapeutic, an antibody, a viral protein, an oligonucleotide, DNA, RNA, a macromolecule having a primary structure and a secondary structure, a protein having an amino acid sequence from an organism, and a polypeptide having an amino acid sequence from an organism;
wherein the protein biomarker is selected from the group consisting of neutrophil gelatinase-associated lipocalin (NGAL), kidney injury molecule-1 (KIM-1), albumin, beta-2 microglobulin, cystatin C, cancer antigen 125 (CA-125), prostate-specific antigen (PSA), human IgG and IgM, ZIKV nonstructural protein 1, and cytokines; and
wherein the protein therapeutic is selected from the group consisting of insulin, monoclonal antibodies, erythropoietin, cytokines, and vaccines.